Author

Nara Yoon

Primary ORCID profile (0000-0001-8937-4196 · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Nara YooniD1 paper · Adelphi University

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Approach:statistical model· 2 Research Focus:cancer & tumor microenvironment· 1 Assay:clinical cohort / trial· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1

Frequent Co-Authors

Andriy MarusykiD· 2 shared Andrew DhawaniD· 1 shared Artem Kaznatcheev· 1 shared Brandon J. Manley· 1 shared Daria MiroshnychenkoiD· 1 shared Daria Myroshnychenko· 1 shared David BasantaiD· 1 shared David Robert Grimes· 1 shared

Activity by Year

2017-2018 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Andriy MarusykORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

The impact of tumor stromal architecture on therapy response and clinical progression

Philipp M. Altrock, Nara Yoon, Joshua A. Bull, Hao Wu, Javier Ruiz-Ramírez, Daria Miroshnychenko, Gregory J. Kimmel, Eunjung Kim, Robert J. Vander Velde, Katarzyna Rejniak, Brandon J. Manley, Fabian Spill, Andriy Marusyk

This paper investigates how tumor stromal architecture influences therapy response and resistance in lung, breast, and kidney cancers using mathematical models, experimental studies, and clinical analysis.

bioRxiv · Oct 24, 2018 · PreprintCancer Biology

Dark selection for JAK/STAT-inhibitor resistance in chronic myelomonocytic leukemia

Artem Kaznatcheev, David Robert Grimes, Robert Vander Velde, Vincent Cannataro, Etienne Baratchart, Andrew Dhawan, Lin Liu, Daria Myroshnychenko, Jake P. Taylor-King, Nara Yoon, Eric Padron, Andriy Marusyk, David Basanta

The paper challenges the classic U-shape model of resistance by proposing alternative population-level models for ruxolitinib resistance in CMML and explores the role of oxygen and cytokine signaling in resistance dynamics.

bioRxiv · Oct 30, 2017 · PreprintCancer Biology